Microbiome Skincare Goes Mainstream, 62% of Americans Use AI for Medical Info, and Health Influence Moves Upstream – Week of 28 April 2026

Welcome to this week’s Digital Health Observer. The dominant thread across this edition is health influence moving upstream, into AI answers, creator-led feeds and identity-driven brand moments, opening a bigger opportunity for brands that can earn trust early and stay useful as decisions take shape. Here is what caught our attention.

Microbiome-Based Skincare Gains Ground as Barrier and Inflammation Story Grows

Consumer interest in microbiome-led skincare is rising as brands pivot from anti-bacterial messaging to skin-barrier and inflammation framing, with category growth driven by claims around prebiotic and postbiotic ingredients. Read more →

62% of Americans Have Used AI for Medical Information

A Harris Poll for Merck Manuals found 62% of US adults have used AI tools for medical information, with the highest usage among adults under 35 and among parents. Read more →

Edelman 2026: Information Overload Is Deepening the Health Trust Gap

The 2026 Edelman Trust Barometer reports trust in health systems remains under pressure while consumers face an ‘information abundant’ environment, with people finding health decisions harder and more divisive than before. Read more →

AI Answers Are Reshaping How Patients Discover Health Brands

A recap from MASHSMD26 reports that AI-generated answers are increasingly the first surface patients see when researching conditions and treatments, shifting the discovery layer away from traditional search results. Read more →

Weight-Loss Brand Strategy Moves Beyond the GLP-1 Injection

The high-leverage marketing window for GLP-1 weight-loss treatments is moving to the period after prescribing begins, with tactics centred on habit-building, identity and reward-based reinforcement during early progress. Read more →

Instagram Menopause Content Is Dominated by Supplement Promotion

A review of menopause content on Instagram found supplement promotion dominates the feed, often led by non-clinical creators promoting products that have limited evidence behind them. Read more →